Good day, and thank you for standing by. Welcome to the Structure Therapeutics top line results from the aleniglipron Phase II Access Program. [Operator Instructions] Please be advised that today's ...
SAN FRANCISCO & SHANGHAI--(BUSINESS WIRE)--Structure Therapeutics Inc. (Structure Therapeutics), formerly known as ShouTi Inc., today announced it closed an oversubscribed $33 million financing round, ...
Miami, FL, April 10, 2026 (GLOBE NEWSWIRE)-- Affiliate Disclosure: This article contains affiliate links. If readers purchase through these links, a commission may be earned at no additional cost.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results